Sampre Nutritions Doubles Share Capital with 1:1 Bonus Issue

1 min read     Updated on 17 Nov 2025, 04:43 PM
scanx
Reviewed by
Jubin VergheseScanX News Team
Overview

Sampre Nutritions Limited has completed a 1:1 bonus share allotment, doubling its paid-up share capital from INR 21.85 crore to INR 43.69 crore. The company issued 43,693,710 bonus shares, increasing the total number of equity shares to 87,387,420. The record date for the bonus issue was set as November 14, 2025. Each share has a face value of INR 5.

24923637

*this image is generated using AI for illustrative purposes only.

Sampre Nutritions Limited, a player in the nutrition sector, has made a significant move to reward its shareholders. The company recently completed a bonus share allotment, effectively doubling its paid-up share capital.

Key Details of the Bonus Issue

Aspect Details
Bonus Ratio 1:1
Number of Bonus Shares Allotted 43,693,710
Face Value of Each Share INR 5
Record Date November 14, 2025

Impact on Share Capital

The bonus issue has had a substantial impact on Sampre Nutritions' share capital structure:

Metric Before Bonus Issue After Bonus Issue
Paid-up Share Capital INR 21.85 crore INR 43.69 crore
Total Number of Equity Shares 43,693,710 87,387,420

This corporate action effectively doubles the company's paid-up share capital, increasing it to INR 43.69 crore. The total number of equity shares has likewise doubled to 87,387,420, each with a face value of INR 5.

Understanding Bonus Shares

Bonus shares are additional shares given to existing shareholders without any additional cost, based on the number of shares they already hold. This 1:1 bonus issue means that for each share held, shareholders received one additional share.

It's important to note that while the number of shares increases, the overall value of a shareholder's stake remains the same, as the stock price typically adjusts proportionately. However, bonus issues can improve stock liquidity and make shares more affordable for potential investors.

Eligibility and Implications

Existing shareholders of Sampre Nutritions as of the record date, November 14, 2025, were eligible to receive these bonus shares. This move by the company may be seen as a way to reward shareholders and potentially increase market interest in the stock.

Investors and market participants will likely be watching closely to see how this corporate action affects Sampre Nutritions' stock performance and market dynamics in the coming days.

like20
dislike

Sampre Nutritions Announces 1:1 Bonus Issue and 1:2 Stock Split

1 min read     Updated on 13 Nov 2025, 09:06 AM
scanx
Reviewed by
Radhika SahaniScanX News Team
Overview

Sampre Nutritions Ltd. has declared a 1:1 bonus issue and a 1:2 stock split, effective November 14, 2023. The bonus issue will double shareholders' share count, while the stock split will reduce the face value from Rs 10 to Rs 5 per share. The last date to buy shares for eligibility is November 13, 2023. The company's stock has gained 466.00% over the past six months and 116.80% year-to-date.

24550569

*this image is generated using AI for illustrative purposes only.

Sampre Nutritions Ltd. has announced significant corporate actions that may interest its shareholders. The company has declared two major changes: a bonus issue and a stock split. These actions are set to take effect soon, with important dates for investors to note.

Key Corporate Actions

Action Details
Bonus Issue 1:1 (One additional share for every share held)
Stock Split 1:2 (Face value reduced from Rs 10 to Rs 5 per share)
Ex-Date November 14, 2023
Record Date November 14, 2023 (Revised from November 11)
Last Date to Buy November 13, 2023

Impact on Shareholders

These corporate actions may potentially benefit shareholders in several ways:

  1. Increased Share Count: The 1:1 bonus issue will double the number of shares held by each investor.
  2. Enhanced Liquidity: The stock split may improve trading liquidity by making shares more affordable.
  3. Unchanged Investment Value: It's important to note that these actions do not change the total value of an investor's holdings.

Stock Performance

Sampre Nutritions' stock has shown notable performance recently:

  • 466.00% gain over the past six months
  • 116.80% increase year-to-date

Investor Considerations

Investors should be aware that to be eligible for these benefits, they must purchase shares by November 13, 2023. The ex-date and record date for both corporate actions is set for November 14, 2023.

While these corporate actions may increase the number of outstanding shares and potentially enhance stock liquidity, investors should remember that they do not inherently increase the value of their investments. As always, it's advisable to make investment decisions based on thorough research and individual financial goals.

like15
dislike
More News on Sampre Nutritions
Explore Other Articles